The image shows the compound Tat-P4-(C5)2 after an injection into the spinal cord. The compound (purple) penetrates the nerve cells of the spinal cord (yellow), but not the surrounding cells (the cell nuclei are blue). Credit: University of Copenhagen.
Researchers from the University of Copenhagen have developed a new way to treat chronic pain which has been tested in mice. With a compound designed and developed by the researchers themselves, they can achieve complete pain relief.
Between seven and ten percent of the world’s population suffers from chronic pain originating from nerves that have been damaged. A disease that can be severely debilitating. Now, researchers from the University of Copenhagen have found a new way to treat the pain.
The treatment has been tested in mice, and the new results have been published in the scientific journal EMBO Molecular Medicine. For more than a decade, the researchers have been working to design, develop and test a drug that shall provide complete pain relief.
“We have developed a new way to treat chronic pain. It is a targeted treatment. That is, it does not affect the general neuronal signalling, but only affects the nerve changes that are caused by the disease,” says co-author Kenneth Lindegaard Madsen, Associate Professor at the Department of Neuroscience, University of Copenhagen.
“We have been working on this for more than ten years. We have taken the process all the way from understanding the biology, inventing and designing the compound to describing how it works in animals, affects their behaviour and removes the pain,” says Kenneth Lindegaard Madsen.
Chronic pain can occur, among other things, after surgery, in people with diabetes, after a blood clot and after an amputation in the form of phantom pain.
Clinical trials as the next step
The compound developed by the researchers is a so-called peptide named Tat-P4-(C5)2. The peptide is targeted and only affects the nerve changes that pose a problem and cause the pain.
In a previous study, the researchers have shown in an animal model that use of the peptide can also reduce addiction. Therefore, the researchers hope that the compound may potentially help pain patients who have become addicted to, for example, opioid pain relievers in particular.
“The compound works very efficiently, and we do not see any side effects. We can administer this peptide and obtain complete pain relief in the mouse model we have used, without the lethargic effect that characterises existing pain-relieving drugs,” says Kenneth Lindegaard Madsen, adding:
“Now, our next step is to work towards testing the treatment on people. The goal, for us, is to develop a drug, therefore the plan is to establish a biotech company as soon as possible so we can focus on this.”
The researchers are now working towards clinical trials in collaboration with, among others, pain researcher Nanna Brix Finnerup, Professor at Aarhus University.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Chronic pain
- Letters to the editor: On political drama dragging through courts, restrictive ballot access, chronic pain
We believe that, too. Let’s keep direct democracy accessible to all. Over 100 million people in America are diagnosed with chronic pain, more than cancer and heart disease combined. That’s about 30% ...
- Pain Control News
Nov. 13, 2023 — A compound -- one of 27 million screened in a library of potential new drugs -- reversed four types of chronic pain in animal studies, according to new research. The small ...
- A woman has an extreme crooked smile after getting Botox for her chronic pain — and the side effect will last months
Brittany Ngo, 38, got Botox for the first time to treat a facial nerve condition. She ended up with a crooked smile, a possible side effect of Botox.
- Chronic fatigue syndrome is not rare, says new CDC survey. It affects 3.3 million U.S. adults
Health officials on Friday released the first nationally representative estimate of how many U.S. adults have chronic fatigue syndrome: 3.3 million.
- Chronic fatigue syndrome is more common than some past studies suggest, CDC says
Health officials on Friday released the first nationally representative estimate of how many U.S. adults have chronic fatigue syndrome: 3.3 million. The Centers for Disease Control and Prevention's ...
Go deeper with Google Headlines on:
Chronic pain
[google_news title=”” keyword=”chronic pain” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Complete pain relief
- Best Herbs for Migraines to take your Pain away
Gingers, peppermint, cloves, and cinnamon tea are some herbs for migraines that have been traditionally used in our homes through centuries, but some of them may have side effects and so should be ...
- Nooro Knee Massager Reviews (Real User Reviews) Nooro Knee Massager Pain-Relieving Device Exposed By Doctors (Must Read)
The Nooro Knee Massager device uses three therapies namely, red light therapy, heat therapy, and massage therapy to target different factors that affect knee health. So far, the Nooro Knee Massager ...
- Top 6 Best OTC Arthritis Supplements in 2023
Whether you’re looking for joint pain relief, increased flexibility, or overall joint health support, we’ve got you covered. Not an NSAID, which are commonly used pain medications that should ...
- Our 'Fundamental Misunderstanding' of Pain
Decades of clinical science show behavioral interventions, which help redirect the anxiety, fear, and negative thoughts that naturally accompany pain, can lessen pain levels and reduce the need for ...
- The PAIN TERMINATOR Opens New Scottsdale Practice
SCOTTSDALE, Ariz., Dec. 7, 2023 /PRNewswire/ -- Dr. Chris Spencer, "The Pain Terminator," announces the opening of his new offices at Gainey Ranch Health Club in Scottsdale, Arizona. Dr. Spencer has ...
Go deeper with Google Headlines on:
Complete pain relief
[google_news title=”” keyword=”complete pain relief” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]